rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
7
|
pubmed:dateCreated |
2003-9-23
|
pubmed:abstractText |
The efficacy of current preventive migraine treatments is limited. In addition, tolerability problems are not infrequent.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0213-4853
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
364-7
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:14505244-Adolescent,
pubmed-meshheading:14505244-Adult,
pubmed-meshheading:14505244-Aged,
pubmed-meshheading:14505244-Aged, 80 and over,
pubmed-meshheading:14505244-Female,
pubmed-meshheading:14505244-Fructose,
pubmed-meshheading:14505244-Humans,
pubmed-meshheading:14505244-Male,
pubmed-meshheading:14505244-Middle Aged,
pubmed-meshheading:14505244-Migraine Disorders,
pubmed-meshheading:14505244-Neuroprotective Agents,
pubmed-meshheading:14505244-Spain
|
pubmed:year |
2003
|
pubmed:articleTitle |
Topiramate for patients with refractory migraine: an observational, multicenter study in Spain.
|
pubmed:affiliation |
University Hospital Marqués de Valdecilla (UC), Santander. juliopascual@telefonica.net
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study
|